Sercombe, L. et al. Napredek in izzivi dostave zdravil s pomočjo liposomov. Spredaj. Farmakol. 6286 (2015).
Giulimondi, F. et al. Interplay of protein corona and immune cells controls blood residency of liposomes. Nat. Komun. 103686 (2019).
Suk, JS, Xu, Q., Kim, N., Hanes, J. & Ensign, LM PEGilacija kot strategija za izboljšanje dostave zdravil in genov na osnovi nanodelcev. Adv. Droga Deliv. Rev. 9928-51 (2016).
Lundqvist, M. et al. Velikost nanodelcev in površinske lastnosti določajo beljakovinsko korono z možnimi posledicami za biološke vplive. Proc. Natl Acad. Sci. ZDA 10514265-14270 (2008).
Ren, H. et al. Role of liposome size, surface charge, and PEGylation on rheumatoid arthritis targeting therapy. ACS Appl. Mater. Vmesniki 1120304-20315 (2019).
Yang, M., Feng, X., Ding, J., Chang, F. & Chen, X. Nanotherapeutics relieve rheumatoid arthritis. J. Nadzor. Izpustite 252108-124 (2017).
Gawne, P. J. et al. PET imaging of liposomal glucocorticoids using 89 Zr-oxine: theranostic applications in inflammatory arthritis. Teranostici 103867-3879 (2020).
Metselaar, J. M. et al. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Revmo. Meglica. 63348-353 (2004).
Matsumura, Y. & Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Rak Res. 466387-6392 (1986).
Danhier, F. To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J. Nadzor. Izpustite 244108-121 (2016).
Davignon, J. L. et al. Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Reumatologija 52590-598 (2013).
Kaplan, M. J. Role of neutrophils in systemic autoimmune diseases. Arthritis Res. Ther. 15219 (2013).
Izar, M. C. O. et al. Monocyte subtypes and the CCR2 chemokine. Clin. Sci. (Lond.) 1311215-1224 (2017).
McInnes, I. B. & Schett, G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 3892328-2337 (2017).
Dammes, N. et al. Konformacijsko občutljivo ciljanje lipidnih nanodelcev za terapevtiko RNA. Nat. Nanotehnol. 161030-1038 (2021).
Sofias, A. M., Andreassen, T. & Hak, S. Nanoparticle ligand-decoration procedures affect in vivo interactions with immune cells. Mol. Pharm. 155754-5761 (2018).
Chu, D., Gao, J. & Wang, Z. Neutrophil-mediated delivery of therapeutic nanoparticles across blood vessel barrier for treatment of inflammation and infection. ACS Nano 911800-11811 (2015).
Karathanasis, E. et al. Selective targeting of nanocarriers to neutrophils and monocytes. Ann Biomed. Inž. 371984-1992 (2009).
Veiga, N. et al. Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target. J. Nadzor. Izpustite 31333-41 (2019).
Vargason, A. M., Anselmo, A. C. & Mitragotri, S. The evolution of commercial drug delivery technologies. Nat. Biomed. inž. 5951-967 (2021).
El Kebir, D. E. & Filep, J. G. Modulation of neutrophil apoptosis and the resolution of inflammation through β2 integrins. Spredaj. Imunol. 460 (2013).
Braeckmans, K. et al. Sizing nanomatter in biological fluids by fluorescence single particle tracking. Nano Lett. 104435-4442 (2010).
Chen, D., Ganesh, S., Wang, W. & Amiji, M. Plasma protein adsorption and biological identity of systemically administered nanoparticles. Nanomedicina 122113-2135 (2017).
De Chermont, Q. L. M. et al. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc. Natl Acad. Sci. ZDA 1049266-9271 (2007).
Smith, W. J. et al. Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes, antibodies and small molecules into biological membranes. Biomateriali 16157 (2018).
Hofkens, W., Storm, G., Van Den Berg, W. B. & Van Lent, P. L. Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis. Int. J. Pharm. 416486-492 (2011).
Kratofil, R. M., Kubes, P. & Deniset, J. F. Monocyte conversion during inflammation and injury. Arterioskler. Thromb. Vasc. Biol. 3735-42 (2017).
Gschwandtner, M., Derler, R. & Midwood, K. S. More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis. Spredaj. Imunol. 102759 (2019).
Seeuws, S. et al. A multiparameter approach to monitor disease activity in collagen-induced arthritis. Arthritis Res. Ther. 12, R160 (2010).
Tu, J. et al. Ontogeny of synovial macrophages and the roles of synovial macrophages from different origins in arthritis. Spredaj. Imunol. 101146 (2019).
Hoeffel, G. et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac–derived macrophages. J. Exp. Med. 2091167-1181 (2012).
Inglis, J. J. et al. Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res. Ther. 9, R113 (2007).
Asquith, D. L., Miller, A. M., McInnes, I. B. & Liew, F. Y. Animal models of rheumatoid arthritis. EUR. J. Immunol. 392040-2044 (2009).
Wipke, B. T. & Allen, P. M. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 1671601-1608 (2001).
Akinc, A. et al. Zgodba Onpattro in klinični prevod nanozdravil, ki vsebujejo zdravila na osnovi nukleinske kisline. Nat. Nanotehnol. 141084-1087 (2019).
Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R. & Van Der Meel, R. Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Acc Chem. Res. 522435-2444 (2019).
Zhu, X. et al. Surface de-PEGylation controls nanoparticle-mediated siRNA delivery in vitro and in vivo. Teranostici 71990-2002 (2017).
Cambré, I. et al. Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis. Nat. Komun. 94613 (2018).
Meghraoui-Kheddar, A., Barthelemy, S., Boissonnas, A. & Combadière, C. Revising CX3CR1 expression on murine classical and non-classical monocytes. Spredaj. Imunol. 111117 (2020).
Kinne, R. W. Macrophages in rheumatoid arthritis. Arthritis Res. Ther. 2189 (2000).
Veiga, N. et al. Celično specifična dostava modificirane mRNA, ki izraža terapevtske proteine, v levkocite. Nat. Komun. 94493 (2018).
Wyatt Shields, C. et al. Cellular backpacks for macrophage immunotherapy. Sci. Adv. 6, eaaz6579 (2020).
Kumar, R. A., Li, Y., Dang, Q. & Yang, F. Monocytes in rheumatoid arthritis: circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis. Int. Imunofarmakol. 65348-359 (2018).
Kim, J. & Sahay, G. Nanomedicine hitchhikes on neutrophils to the inflamed lung. Nat. Nanotehnol. 171-2 (2021).
Palchetti, S. et al. The protein corona of circulating PEGylated liposomes. Biochim. Biophys. Acta Biomembr. 1858189-196 (2016).
Schöttler, S. et al. Adsorpcija beljakovin je potrebna za prikriti učinek nanonosilcev, prevlečenih s poli(etilen glikolom) in poli(fosfoestrom). Nat. Nanotehnol. 11372-377 (2016).
Francia, V., Schiffelers, RM, Cullis, PR & Witzigmann, D. Biomolekularna korona lipidnih nanodelcev za gensko terapijo. Biokonjugat Chem. 312046-2059 (2020).
Dale, D. C., Boxer, L., & Liles, W. C. The phagocytes: neutrophils and monocytes. Blood 112935-945 (2008).
Leuschner, F. et al. Terapevtsko utišanje siRNA v vnetnih monocitih pri miših. Nat. Biotehnol. 291005-1010 (2011).
Novobrantseva, T. I. et al. Systemic RNAi-mediated gene silencing in nonhuman primate and rodent myeloid cells. Mol. Ther. Nukleinska kislina 1, e4 (2012).
Li, C. et al. Mehanizmi prirojene in adaptivne imunosti na cepivo Pfizer-BioNTech BNT162b2. Nat. Imunol. 23543-555 (2022).
Lenart, K. et al. A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses. Mol. Ther. Metode Clin. Dev. 27309-323 (2022).
Jafarzadeh, A., Chauhan, P., Saha, B., Jafarzadeh, S. & Nemati, M. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions. Life Sci. 257118102 (2020).
Martinez, F. O., Combes, T. W., Orsenigo, F. & Gordon, S. Monocyte activation in systemic Covid-19 infection: assay and rationale. eBiomedicina 59102964 (2020).
Zhang, D. et al. COVID‐19 infection induces readily detectable morphologic and inflammation‐related phenotypic changes in peripheral blood monocytes. J. Leukoc. Biol. 10913-22 (2020).
Pence, B. D. Severe COVID-19 and aging: are monocytes the key? GeroScience 421051-1061 (2020).
Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R. & Salem, R. The COVID-19 cytokine storm; what we know so far. Spredaj. Imunol. 111446 (2020).
Yoshimura, T. The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments. Citokinov 9871-78 (2017).
Parihar, A., Eubank, T. D. & Doseff, A. I. Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate Immun. 2204-215 (2010).
Yang, J., Zhang, L., Yu, C., Yang, X. F. & Wang, H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res. 21 (2014).
Lammers, T. et al. Dexamethasone nanomedicines for COVID-19. Nat. Nanotehnol. 15622-624 (2020).
Benchimol, M. J., Bourne, D., Moghimi, S. M. & Simberg, D. Pharmacokinetic analysis reveals limitations and opportunities for nanomedicine targeting of endothelial and extravascular compartments of tumors. J. Drug Target. 27690-698 (2019).
Fang, J., Nakamura, H. & Maeda, H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Droga Deliv. Rev. 63136-151 (2011).
Brocato, T. A. et al. Understanding the connection between nanoparticle uptake and cancer treatment efficacy using mathematical modeling. Sci. Rep. 87538 (2018).
Avnir, Y. et al. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. Artritis Rheum. 58119-129 (2008).
Avnir, Y. et al. Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids. PLoS ONE 6, e25721 (2011).
Verbeke, R. et al. Broadening the message: a nanovaccine co-loaded with messenger RNA and α-GalCer induces antitumor immunity through conventional and natural killer T cells. ACS Nano 131655-1669 (2019).
Kulkarni, JA et al. Od fuzije odvisna tvorba lipidnih nanodelcev, ki vsebujejo makromolekularne koristne obremenitve. Nanoscele 119023-9031 (2019).
Kulkarni, JA et al. O nastanku in morfologiji lipidnih nanodelcev, ki vsebujejo ionizirajoče kationske lipide in siRNA. ACS Nano 124787-4795 (2018).
Hirota, S., De Ilarduya, C. T., Barron, L. G. & Szoka, F. C. Simple mixing device to reproducibly prepare cationic lipid-DNA complexes (lipoplexes). Biotehnike 27286-290 (1999).
Kulkarni, J. A. et al. Rapid synthesis of lipid nanoparticles containing hydrophobic inorganic nanoparticles. Nanoscele 913600-13609 (2017).
Kannan, K., Ortmann, R. A. & Kimpel, D. Animal models of rheumatoid arthritis and their relevance to human disease. Patofiziologije 12167-181 (2005).
Seemann, S., Zohles, F. & Lupp, A. Comprehensive comparison of three different animal models for systemic inflammation. J. Biomed. Sci. 2460 (2017).
- Distribucija vsebine in PR s pomočjo SEO. Okrepite se še danes.
- PlatoData.Network Vertical Generative Ai. Opolnomočite se. Dostopite tukaj.
- PlatoAiStream. Web3 Intelligence. Razširjeno znanje. Dostopite tukaj.
- PlatoESG. Avtomobili/EV, Ogljik, CleanTech, Energija, Okolje, sončna energija, Ravnanje z odpadki. Dostopite tukaj.
- BlockOffsets. Posodobitev okoljskega offset lastništva. Dostopite tukaj.
- vir: https://www.nature.com/articles/s41565-023-01444-w
- : je
- ][str
- 07
- 1
- 10
- 11
- 116
- 12
- 13
- 14
- 15%
- 16
- 167
- 17
- 19
- 1999
- 20
- 2000
- 2001
- 2005
- 2008
- 2011
- 2012
- 2013
- 2014
- 2015
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 30
- 31
- 32
- 33
- 36
- 39
- 40
- 46
- 49
- 50
- 51
- 60
- 65
- 66
- 67
- 7
- 70
- 72
- 8
- 9
- a
- računi
- akumulacija
- čez
- Aktiviranje
- dejavnost
- zdravilo
- Izobraževanje odraslih
- napredek
- vplivajo
- Agent
- Staranja
- AL
- Analiza
- in
- živali
- Protitelesa
- aplikacije
- pristop
- SE
- članek
- AS
- povezan
- privlačen
- avtoimunski
- ovira
- koristi
- med
- Poleg
- biomarker
- Biomateriali
- kri
- by
- rak
- zdravljenje raka
- ccl2
- celica
- Celice
- celični
- izzivi
- chang
- Spremembe
- naboj
- chen
- krožijo
- Kroženje
- klik
- Ambulanta
- klinični
- komercialna
- Primerjava
- celovito
- Koncept
- povezava
- Prispevek
- nadzor
- Nadzor
- konvencionalne
- Pretvorba
- Corona
- Covid-19
- Okužba s COVID-19
- citokinov
- škoda
- Smrt
- dostava
- To
- Ugotovite,
- določa
- dev
- naprava
- drugačen
- bolezen
- bolezni
- Pes
- Odmerek
- diski
- drog
- Droge
- med
- dinamično
- e
- E&T
- učinek
- učinkovitost
- učinkovite
- Izboljša
- praporščak
- bistvena
- Eter (ETH)
- ocenili
- evolucija
- Izkoristite
- izraz
- dejavniki
- ne uspe
- daleč
- Lastnosti
- za
- Oblikovanje
- iz
- Prihodnost
- GAO
- Kako
- http
- HTTPS
- človeškega
- i
- identiteta
- ii
- slikanje
- imunski
- imuniteta
- Vplivi
- posledice
- izboljšanju
- in
- Poveča
- okužba
- vnetje
- vnetno
- prirojeno
- vpogledi
- interakcije
- v
- vključeni
- samo
- Ključne
- Kim
- Vedite
- Spoznanja
- li
- omejitve
- podloga
- LINK
- Jetra
- lokalna
- Lokalizacija
- makrofagi
- matematični
- Matrix
- mehanska
- Mehanizem
- Mehanizmi
- Sporočilo
- Messenger
- Metode
- miši
- Miller
- mladoletnika
- Mešanje
- Model
- modeliranje
- modeli
- spremembe
- monitor
- več
- mRNA
- Nanomedicina
- nanotehnologija
- naravna
- Narava
- omrežij
- Novo
- roman
- of
- on
- Priložnosti
- delec
- periferni
- hišne
- Plazma
- platon
- Platonova podatkovna inteligenca
- PlatoData
- mogoče
- potencial
- pretežno
- Pripravimo
- Načela
- Postopki
- proizvodnja
- napredovanje
- Lastnosti
- Beljakovine
- Beljakovine
- kakovost
- Količina
- hitro
- Uredi
- ustreznost
- daljinsko
- obvezna
- Resolucija
- Odgovor
- odgovorov
- razkrivajo
- Razkrije
- RNA
- robusten
- vloga
- vloge
- s
- SARS
- SCI
- selektivno
- huda
- Enostavno
- saj
- sam
- Velikosti
- majhna
- So
- doslej
- specifična
- Stealth
- Storm
- Zgodba
- Strategija
- Močno
- superior
- Površina
- preživetje
- trajno
- sistemsko
- sistemsko
- T celice
- ciljna
- ciljanje
- Tehnologije
- Tehnologija
- kot
- O
- Prihodnost
- njihove
- Terapevtsko
- terapevtiki
- terapija
- tretja
- 3
- skozi
- do
- Sledenje
- prevod
- prevoz
- zdravljenje
- Zdravljenje
- tumor
- tip
- razumevanje
- edinstven
- edinstvene lastnosti
- uporabo
- Cepivo
- Plovilo
- vivo
- W
- we
- Kaj
- Kaj je
- z
- X
- zefirnet